title: Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study.
authors.affiliation: Centre for Ophthalmology, University Eye Clinic Tuebingen, Tuebingen, Germany.
authors.forename: Kai
authors.initials: K
authors.lastname: Januschowski
authors.affiliation: Centre for Ophthalmology, University Eye Clinic Tuebingen, Tuebingen, Germany.
authors.forename: Spyridon
authors.initials: S
authors.lastname: Dimopoulos
authors.affiliation: Centre for Ophthalmology, University Eye Clinic Tuebingen, Tuebingen, Germany.|Knappschaftsaugenklinik, Sulzbach-Saar, Germany.
authors.forename: Peter
authors.initials: P
authors.lastname: Szurman
authors.affiliation: University Eye Hospital, University of Goettingen, Goettingen, Germany.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Feltgen
authors.affiliation: Neurocomputation and Neuroimaging Unit, Department of Education and Psychology, Freie Universität Berlin, Berlin, Germany.
authors.forename: Bernhard
authors.initials: B
authors.lastname: Spitzer
authors.affiliation: University Eye Hospital Freiburg, Freiburg, Germany.
authors.forename: Amelie
authors.initials: A
authors.lastname: Pielen
authors.affiliation: University Eye Hospital, University of Leipzig, Leipzig, Germany.
authors.forename: Matus
authors.initials: M
authors.lastname: Rehak
authors.affiliation: Department of Ophthalmology, St. Franziskus Hospital, Muenster, Germany.
authors.forename: Georg
authors.initials: G
authors.lastname: Spital
authors.affiliation: Department of Ophthalmology, University of Bonn, Bonn, Germany.
authors.forename: Carsten H
authors.initials: CH
authors.lastname: Meyer
authors.affiliation: Centre for Ophthalmology, University Eye Clinic Tuebingen, Tuebingen, Germany.
authors.forename: Gesine B
authors.initials: GB
authors.lastname: Szurman
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000068258:Bevacizumab / Q000008:administration & dosage*; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology; D012170:Retinal Vein Occlusion / Q000150:complications*; D019233:Retreatment; D012189:Retrospective Studies; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity / Q000187:drug effects / Q000502:physiology
chemical_list: D020533:Angiogenesis Inhibitors; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab